Abstract:Drug resistance and metastasis are considered to be the major factors leading to tragic prognosis and high rate of mortality in cancer patients. Recent evidences suggest that cancer stem cells (CSCs) possess the essential property of self‐protection from chemotherapy, exhibit the ability to self‐renew and generate cancer cells by asymmetric cell division. Nevertheless, the currently known mechanisms likely explain only the tip of an iceberg about CSC property, acquisition and maintenance. The information from data mining is still limited due to the rarity of CSCs in clinical samples. Ovarian cancer is the most lethal malignancy of the female reproductive system. CSCs in ovarian cancers are considered to acquire the molecular armaments of stem cells, which carry stem cell property and can determine the level of malignant potential of the cancer cells, similar to the findings in other cancer cell types. In this study, we introduced a set of defined factors (OCT3/4, SOX2, KLF4 and c‐Myc) into human serous ovarian cancer cells (OVCAR‐3 cell line) through Sendai virus reprogramming, aiming to induce CSC properties in the cancer cells. We observed that the ovarian cancer cells transduced with the four Yamanaka factors showed significantly enhanced pluripotent stem cell properties and drug resistance. We thus named the cells with CSC properties as induced ovarian CSCs (iOCSCs). These iOCSCs could be maintained and expanded up to at least 40 passages. Consistent with the original ovarian cancer cells, iOCSCs could be differentiated into ovarian lineage cells, displaying markers as CA125 and CK‐7. Intriguingly, iOCSCs also acquired the ability to differentiate into cells belonging to the three embryonic germ layers, similar to human iPS cells or ES cells. This present approach thus makes it feasible to obtain abundant CSCs from ovarian cancer cell line to support our understanding and in‐depth research into CSCs and hopefully can help in developing new therapeutic strategies to treat ovarian cancers. Support or Funding Information Research supported by National Science Council of the Republic of China (NSC) and National Taiwan University Hospital (NTUH), Taiwan

Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line

[Identification and Characterization of Ovarian Cancer Stem-Like Cells from Primary Tumor.].

Isolation and culture of cancer stem cells from ovarian cancer tissues and malignant ascites

Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.

Enrichment and Characterization of Ovarian Cancer Stem Cells and Its Potential Clinical Application

Characterization of Primary Ovarian Cancer Cells in Different Culture Systems.

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma

Establishment and Characterization of Primary Human Ovarian Cancer Stem Cell Line (CD44+ve)

Expression of Aldehyde Dehydrogenase and Cd133 Defines Ovarian Cancer Stem Cells

Cyclin D1 Affects Epithelial–mesenchymal Transition in Epithelial Ovarian Cancer Stem Cell-Like Cells

Cancer Stem-Like Cells Can Be Isolated with Drug Selection in Human Ovarian Cancer Cell Line SKOV3.

Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

[Isolation and Identification of Cancer Stem Cells from Primary Human Ovarian Cancer Tissues].

Identification Of A Potential Ovarian High-Grade Serous Cancer Stem Cell Marker And Its Clinicopathological Associations

Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.

Description of the CD 133 + Subpopulation of the Human Ovarian Cancer Cell Line OVCAR 3

Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening.

Identification and Characterization of Cancer Stem-Like Cells from Primary Carcinoma of the Cervix Uteri

SURF4 Maintains Stem-Like Properties Via BIRC3 in Ovarian Cancer Cells.

Establishment of induced Ovarian Cancer Stem Cells by Defined Factors